Brief: Nanovibronix Reports Third Quarter 2021 Financial Results

ENvue Medical

16/11/2021 13:46

Nov 16 (Reuters) - Nanovibronix Inc  NAOV.O :
    * NANOVIBRONIX REPORTS THIRD QUARTER 2021 FINANCIAL RESULTS
    * Q3 REVENUE ROSE 233 PERCENT TO $499,000
    * Q3 LOSS PER SHARE $0.26

Source text for Eikon:  ID:nBw3Q6gcta 
Further company coverage:  NAOV.O 

 ((Reuters.Briefs@thomsonreuters.com;))